Sugi Predict

Sugi Predict / Compounds / SCHEMBL29436335

SCHEMBL29436335

SCHEMBL29436335

CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ IL23R Q5VWK5 15/20 0.64
▸ NPBWR1 P48145 2/20 0.64
▸ GLP1R P43220 1/20 0.59
▸ GCGR P47871 1/20 0.59
▸ GIPR P48546 1/20 0.59
▸ NR3C1 P04150 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29724643 0.95 NPBWR1 (0.61) IL23RNPBWR1GLP1RGCGRGIPR
SCHEMBL31514295 0.93 NPBWR1 (0.69) IL23RNPBWR1GLP1RGCGRGIPR
SCHEMBL30486085 0.91 IL23R (0.60) IL23RNPBWR1GLP1RGCGRGIPR
SCHEMBL30486083 0.91 IL23R (0.60) IL23RNPBWR1GLP1RGCGRGIPR
SCHEMBL30486082 0.91 IL23R (0.60) IL23RNPBWR1GLP1RGCGRGIPR
SCHEMBL31683311 0.91 GLP1R (0.67) IL23RNPBWR1GLP1RGCGRGIPR
SCHEMBL30446094 0.89 RXFP1 (0.70) IL23RGLP1RGCGRGIPR
SCHEMBL29973052 0.89 NPBWR1 (0.68) IL23RNPBWR1
SCHEMBL30906492 0.88 GLP1R (0.70) GLP1RGCGRGIPRNR3C1
SCHEMBL30220493 0.88 RXFP1 (0.65) IL23RNPBWR1GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473332-B2 Modified peptides and associated methods of use ADVANCED TECH FOR NOVEL THERAPEUTICS LLC (US) 2025-11-18 — — US disclosed
US-20240083948-A1 MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE ADVANCED TECHNOLOGIES FOR NOVEL THERAPEUTICS, LLC (US) 2024-03-14 — — US disclosed
US-11820837-B2 Modified peptides and associated methods of use ADVANCED TECHNOLOGIES FOR NOVEL THERAPEUTICS, LLC (US) 2023-11-21 — — US disclosed
EP-4025585-A1 MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE Advanced technologies for novel therapeutics, LLC (US) 2022-07-13 — — EP disclosed
CN-114174316-A Modified peptides and related methods of use 新颖疗法的先进技术有限责任公司 2022-03-11 — — CN disclosed
Send feedback